Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography

Madeline B Torres; Matthew E B Dixon; Niraj J Gusani

doi:10.1016/j.soc.2021.07.006

Undertreatment of Pancreatic Cancer: The Intersection of Bias, Biology, and Geography

Surg Oncol Clin N Am. 2022 Jan;31(1):43-54. doi: 10.1016/j.soc.2021.07.006. Epub 2021 Oct 19.

Authors

Madeline B Torres¹, Matthew E B Dixon², Niraj J Gusani³

Affiliations

¹ General Surgery, Department of Surgery, Penn State Health Milton S. Hershey Medical Center, 500 University Avenue MC H149, Hershey, PA 17033, USA. Electronic address: https://twitter.com/MadelineBTorres.
² Division of Surgical Oncology, Penn State Health Milton S. Hershey Medical Center, 500 University Avenue MC H070, Hershey, PA 17036, USA. Electronic address: https://twitter.com/mebdixon.
³ Section of Surgical Oncology, Baptist MD Anderson Cancer Center, 1301 Palm Avenue, Jacksonville, FL 32207, USA. Electronic address: [email protected].

PMID: 34776063
DOI: 10.1016/j.soc.2021.07.006

Abstract

Pancreatic cancer is the third leading cause of cancer deaths in the United States. Black patients with pancreatic cancer experience higher incidence and increased mortality. Although racial biologic differences exist, socioeconomic status, insurance type, physician bias, and patient beliefs contribute to the disparities in outcomes observed among patients who are Black, indigenous, and people of color.

Keywords: Disparities; High volume; Multimodality therapy; Pancreatic cancer; Race; Socioeconomic; Surgery.

Publication types

Review

MeSH terms

Biology
Geography
Healthcare Disparities*
Humans
Incidence
Pancreatic Neoplasms* / therapy
Socioeconomic Factors
United States